Posted in | News | Business | Chemistry

Arkema to Buy Specialty Chemical Project from SEPPIC

Arkema will acquire the specialty alcoxylate business project from SEPPIC.

The company will be expanding its surfactant series and strengthening its position in this industrial niche market, by means of this latest range of products. The company’s acquisition of specialty alcoxylate industrial business from SEPPIC has involved the purchase of a first-class industrial location in Belgium. This business has been included in the Specialty Chemicals BU (CECA) and Performance Products business section.

CECA may extend the specialty surfactant series, which has been planned for niche markets like industrial detergency, mixture of warm asphalt for construction of road and for the oil and gas production business, by combining the manufacturing facilities that harmonizes its two locations at Châteauroux and Feuchy.

The company has considered alcoxylate to be a main constituent for manufacturing rheological additives, which were utilized in high performance concrete additives and paints for advanced engineering structures in civil works like high-rise bridges and buildings. Significant development of the products manufactured by Coatex, a subsidiary of Arkema, will be enhanced by this business acquisition.

Source: http://www.arkema.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, March 18). Arkema to Buy Specialty Chemical Project from SEPPIC. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=31117.

  • MLA

    Chai, Cameron. "Arkema to Buy Specialty Chemical Project from SEPPIC". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=31117>.

  • Chicago

    Chai, Cameron. "Arkema to Buy Specialty Chemical Project from SEPPIC". AZoM. https://www.azom.com/news.aspx?newsID=31117. (accessed April 25, 2024).

  • Harvard

    Chai, Cameron. 2019. Arkema to Buy Specialty Chemical Project from SEPPIC. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=31117.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.